Description: PALFORZIA is the first and only FDA-approved oral immunotherapy to help reduce the severity of allergic reactions to peanuts, including anaphylaxis, in children aged 4 through 17.
This website is intended for U.S. healthcare professionals only.
To enable certain features and improve your experience with us, this website requires cookies to be stored on your computer. To find out more about the cookies we use, please see our Privacy Notice .
Please confirm if you are a U.S. healthcare professional to proceed. By choosing an option, you are accepting our cookie policy.